Hereditary elliptocytosis medical therapy: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Hereditary elliptocytosis}} {{CMG}} ==Overview== ==Medical Therapy== The vast majority of those with hereditary elliptocytosis require no treatment whatsoever. Th...")
 
No edit summary
Line 5: Line 5:
==Overview==
==Overview==
==Medical Therapy==
==Medical Therapy==
The vast majority of those with hereditary elliptocytosis require no treatment whatsoever. They have a mildly increased risk of developing [[gallstones]], which is treated surgically with a [[cholecystectomy]] if pain becomes problematic.
* Management of hereditary elliptocytosis includes [[supportive therapy]].
 
* The vast majority of patients being diagnosed with hereditary elliptocytosis do not need any medication.
[[Folate]] helps to reduce the extent of haemolysis in those with significant haemolysis due to hereditary elliptocytosis.
* However HE patients with sever anemia may require [[blood transfusions]].
* [[Phototherapy]] may be required in new borns with [[jaundice]], specially in HPP and  Neonatal poikilocytosis subtypes of HE.
* There exists no definite treatment for membrane defect in HE.
* Moreover these patients may have folate deficiency due to hemolysis, so folic acid supplementation or [[folic acid]] rich diet(green leafy vegetables) is advised.
* [[Folate]] helps to reduce the extent of hemolysis in those with significant hemolysis due to hereditary elliptocytosis.<ref name="pmid21251470">{{cite journal| author=Barcellini W, Bianchi P, Fermo E, Imperiali FG, Marcello AP, Vercellati C et al.| title=Hereditary red cell membrane defects: diagnostic and clinical aspects. | journal=Blood Transfus | year= 2011 | volume= 9 | issue= 3 | pages= 274-7 | pmid=21251470 | doi=10.2450/2011.0086-10 | pmc=3136593 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21251470  }}</ref>


==References==
==References==

Revision as of 19:04, 31 August 2018

Hereditary elliptocytosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hereditary elliptocytosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hereditary elliptocytosis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hereditary elliptocytosis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hereditary elliptocytosis medical therapy

CDC on Hereditary elliptocytosis medical therapy

Hereditary elliptocytosis medical therapy in the news

Blogs on Hereditary elliptocytosis medical therapy

Directions to Hospitals Treating Hereditary elliptocytosis

Risk calculators and risk factors for Hereditary elliptocytosis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Medical Therapy

  • Management of hereditary elliptocytosis includes supportive therapy.
  • The vast majority of patients being diagnosed with hereditary elliptocytosis do not need any medication.
  • However HE patients with sever anemia may require blood transfusions.
  • Phototherapy may be required in new borns with jaundice, specially in HPP and  Neonatal poikilocytosis subtypes of HE.
  • There exists no definite treatment for membrane defect in HE.
  • Moreover these patients may have folate deficiency due to hemolysis, so folic acid supplementation or folic acid rich diet(green leafy vegetables) is advised.
  • Folate helps to reduce the extent of hemolysis in those with significant hemolysis due to hereditary elliptocytosis.[1]

References

  1. Barcellini W, Bianchi P, Fermo E, Imperiali FG, Marcello AP, Vercellati C; et al. (2011). "Hereditary red cell membrane defects: diagnostic and clinical aspects". Blood Transfus. 9 (3): 274–7. doi:10.2450/2011.0086-10. PMC 3136593. PMID 21251470.

Template:WH Template:WS